Strengthening capacity in hospitals to reduce perinatal morbidity and mortality through a codesigned intervention package: protocol for a realist evaluation as part of a stepped-wedge trial of the Action Leveraging Evidence to Reduce perinatal morTality and morbidity (ALERT) in sub-Saharan Africa project.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
19 04 2022
Historique:
entrez: 20 4 2022
pubmed: 21 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

Despite a strong evidence base for developing interventions to reduce child mortality and morbidity related to pregnancy and delivery, major knowledge-implementation gaps remain. The Action Leveraging Evidence to Reduce perinatal morTality and morbidity (ALERT) in sub-Saharan Africa project aims to overcome these gaps through strengthening the capacity of multidisciplinary teams that provide maternity care. The intervention includes competency-based midwife training, community engagement for study design, mentoring and quality improvement cycles. The realist process evaluation of ALERT aims at identifying and testing the causal pathway through which the intervention achieves its impact. This realist process evaluation complements the effectiveness evaluation and the economic evaluation of the ALERT intervention. Following the realist evaluation cycle, we will first elicit the initial programme theory on the basis of the ALERT theory of change, a review of the evidence on adoption and diffusion of innovations and the perspectives of the stakeholders. Second, we will use a multiple embedded case study design to empirically test the initial programme theory in two hospitals in each of the four intervention countries. Qualitative and quantitative data will be collected, using in-depth interviews with hospital staff and mothers, observations, patient exit interviews and (hospital) document reviews. Analysis will be guided by the Intervention-Actors-Context-Mechanism-Outcome configuration heuristic. We will use thematic coding to analyse the qualitative data. The quantitative data will be analysed descriptively and integrated in the analysis using a retroductive approach. Each case study will end with a refined programme theory (in-case analysis). Third, we will carry out a cross-case comparison within and between the four countries. Comparison between study countries should enable identifying relevant context factors that influence effectiveness and implementation, leading to a mid-range theory that may inform the scaling up the intervention. In developing this protocol, we paid specific attention to cultural sensitivity, the PACTR202006793783148.

Identifiants

pubmed: 35440457
pii: bmjopen-2021-057414
doi: 10.1136/bmjopen-2021-057414
pmc: PMC9020280
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e057414

Investigateurs

Ahossi Angèle Florence Laure (AAF)
Andrea B Pembe (AB)
Ann-Beth Nygaard Moller (AN)
Antoinette Sognonvi (A)
Armelle Vigan (A)
Banougnin Bolade Hamed (BB)
Beatrice Mwilike (B)
Kéfilath Bello (K)
Bianca Kandeya (B)
Christelle Boyi Metogni (CB)
Bruno Marchal (B)
Claudia Hanson (C)
Dickson Mkoka (D)
Effie Chipeta (E)
Elizabeth Ombeva Ayebare (EO)
Fadhlun M Alwy Al-Beity (FMA)
Gertrude Namazzi (G)
Gisele Houngbo (G)
Gottfried Agballa (G)
Hashim Hounkpatin (H)
Helga Naburi (H)
Helle Mölsted Alvesson (HM)
Hussein L Kidanto (HL)
Jean-Paul Dossou (JP)
Joanne Welsh (J)
Joseph Akuze (J)
Josephine Babirye (J)
Kristi Sidney Annerstedt (KS)
Lenka Benova (L)
Lilian Mselle (L)
Mechthild Gross (M)
Muzdalifat Abeid (M)
Nicola Orsini (N)
Peter Waiswa (P)
Philip Wanduru (P)
Razak Mussa (R)
Regine Unkels (R)
Rian Snijders (R)
Samuel Meja (S)
Schadrac Agbla (S)
Therese Delvaux (T)
Tumbwene Mwansisya (T)
Virginia Castellano Pleguezuelo (VC)
William Stones (W)
Wim Van Damme (WV)
Yesaya Z Nyirenda (YZ)
Zamoyoni Julius (Z)

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Implement Sci. 2019 Dec 11;14(1):103
pubmed: 31823787
Transl Behav Med. 2020 Feb 3;10(1):168-178
pubmed: 30476259
BMC Health Serv Res. 2021 Dec 11;21(1):1324
pubmed: 34895216
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Evaluation (Lond). 2016 Jul;22(3):286-303
pubmed: 27478401
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Lancet Glob Health. 2018 Nov;6(11):e1163-e1175
pubmed: 30309799
Implement Sci. 2020 May 4;15(1):27
pubmed: 32366269
Implement Sci. 2021 Jan 7;16(1):4
pubmed: 33413504
BMJ Glob Health. 2019 Oct 31;4(5):e001638
pubmed: 31749993
Qual Health Care. 1998 Sep;7(3):149-58
pubmed: 10185141
Implement Sci. 2018 Nov 16;13(1):138
pubmed: 30442165
Implement Sci. 2012 May 31;7:50
pubmed: 22651257
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
PLoS One. 2019 Jan 16;14(1):e0210565
pubmed: 30650129
BMC Med. 2016 Jun 24;14(1):96
pubmed: 27342217
Lancet. 2016 Oct 8;388(10053):1725-1774
pubmed: 27733285
Int J Qual Health Care. 2005 Oct;17(5):447-54
pubmed: 15872024
Lancet Glob Health. 2020 Aug;8(8):e1061-e1070
pubmed: 32710862

Auteurs

Ibukun-Oluwa Omolade Abejirinde (IO)

International Program Evaluation Unit, Centre for Global Child Health, Hospital for Sick Children, Toronto, Ontario, Canada.
Division of Social & Behavioural Health Sciences, University of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.

Virginia Castellano Pleguezuelo (V)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.

Lenka Benova (L)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium.

Jean-Paul Dossou (JP)

Centre de Recherche en Reproduction Humaine et en Démographie, Cotonou, Benin.

Claudia Hanson (C)

Department of Public Global Health, Karolinska Institute, Stockholm, Sweden.

Christelle Boyi Metogni (CB)

Centre de Recherche en Reproduction Humaine et en Démographie, Cotonou, Benin.

Samuel Meja (S)

University of Malawi College of Medicine, Blantyre, Malawi.

D A Mkoka (DA)

Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Gertrude Namazzi (G)

Department of Health Policy Planning and Management, Makerere University, Kampala, Uganda.

Kristi Sidney (K)

Global Public Health, Karolinska Institute, Stockholm, Sweden.

Bruno Marchal (B)

Department of Public Health, Institute of Tropical Medicine, Antwerpen, Belgium BMarchal@itg.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH